SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 16 )*
ELI LILLY AND COMPANY
(Name of Issuer)
COMMON STOCK, WITHOUT PAR VALUE
(Title of Class of Securities)
532457-10-8
(CUSIP Number)
Check the following box if a fee is being paid with this statement.
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1; and (2) has
filed no amendment subsequent thereto reporting beneficial ownership
of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
(Continued on following page(s))
<PAGE>
CUSIP No. 532457-10-8
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Lilly Endowment, Inc.
Federal I.D. No. 35-0868122
2. Check the appropriate box if a member of a group
N/A
3.
4. Citizenship or Place of Organization
Indiana
5. Sole Voting Power
93,691,684
6. Shared Voting Power
0
7. Sole Dispositive Power
93,694,684
8. Shared Dispositive Power
0
9. Aggregate Amount Beneficially Owned by each Reporting Person
93,694,684
10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares
11. Percent of Class Represented by Amount in Row 9
17.01%
12. Type of Reporting Person
CO
<PAGE>
ITEM 1(A). NAME OF ISSUER.
Eli Lilly and Company.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES.
307 East McCarty Street, Indianapolis, Indiana 46225.
ITEM 2(A). NAME OF PERSON FILING.
This statement is filed by Lilly Endowment, Inc., a
not-for-profit corporation organized under the laws of the State of
Indiana. Lilly Endowment, Inc., is an organization described in
Section 501(c)(3) of the Internal Revenue Code of 1986 and is a private
foundation under Section 509(a) of the Code.
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE,
RESIDENCE.
The address of the principal business office of Lilly Endowment,
Inc., is 2801 North Meridian Street, Indianapolis, Indiana 46208.
ITEM 2(C). CITIZENSHIP.
Indiana.
ITEM 2(D). TITLE OF CLASS OF SECURITIES.
Common Stock, without par value.
ITEM 2(E). CUSIP NUMBER.
532457-10-8
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B) OR
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in Section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the
Act
(d) [ ] Investment Company registered under Section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under Section 203 of the
Investment Advisors Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income
Security Act of 1974 or Endowment Fund; see
Section 240.13d-1(b)(1)(ii)(F)
(g) [ ] Parent Holding Company, in accordance with
Section 240.13d-1(b)(1)(ii)(G)
(h) [ ] Group, in accordance with
Section 240.13d-1(b)(1)(ii)(H)
Inapplicable.
ITEM 4. OWNERSHIP.
If the percent of the class owned, as of December 31 of the year
covered by the statement, or as of the last day of any month described in
Rule 13d-1(b)(2), if applicable, exceeds five percent, provide the
following information as of that date and identify those shares which there
is a right to acquire.
The following information is provided as of December 31, 1995:
ITEM 4(A). AMOUNT BENEFICIALLY OWNED:
93,694,684. None of such shares are deemed to be beneficially
owned by reason of the possession of Lilly Endowment, Inc., of a right to
acquire such shares.
ITEM 4(B). PERCENT OF CLASS:
17.01%
ITEM 4(C). NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) sole power to vote or direct the vote:
93,694,684
(ii) shared power to vote or to direct the vote:
0
(iii) sole power to dispose or to direct the disposition of:
93,694,684
(iv) shared power to dispose or to direct the disposition of:
0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following
[ ].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON.
The two beneficiaries of a testamentary trust of which Lilly
Endowment, Inc., is a trustee have the right to receive or the power to
direct the receipt of dividends from, and the proceeds from the sale of,
1,536,000 of the shares reported above as beneficially owned by Lilly
Endowment, Inc. The trust owns less than 5% of the common stock of Eli
Lilly and Company that was outstanding on December 31, 1995.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT
HOLDING COMPANY.
Inapplicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Inapplicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Inapplicable
ITEM 10. CERTIFICATION.
Inapplicable.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: January 22, 1996 /S/ DAVID D. BIBER
Signature
David D. Biber, Treasurer
LILLY ENDOWMENT, INC.
Name, Title